In this study, we found that, in the presence of neutralizing B8-dIgA1 or B8-dIgA2 antibodies, SARS-CoV-2 might use the cellular receptor CD209 for capture or attachment, which likely expanded the use of CD209+ cells, leading to NT infection and trans-infection. The gene discussed is CD209; the disease is infection.